64 related articles for article (PubMed ID: 11521048)
21. Toll, a new piece in the puzzle of innate immunity.
Wright SD
J Exp Med; 1999 Feb; 189(4):605-9. PubMed ID: 9989974
[No Abstract] [Full Text] [Related]
22. Toll-like receptors in the spotlight.
O'Neill LA; Brown Z; Ward SG
Nat Immunol; 2003 Apr; 4(4):299. PubMed ID: 12660723
[No Abstract] [Full Text] [Related]
23. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
[TBL] [Abstract][Full Text] [Related]
24. Variations in LPS responsiveness among different mouse substrains of C3H lineage and their congenic derivative sublines.
Silvia OJ; Urosevic N
Immunogenetics; 1999 Dec; 50(5-6):354-7. PubMed ID: 10630301
[No Abstract] [Full Text] [Related]
25. Drosophila, the savvy exterminator.
Tan BH; Modlin RL
Nat Immunol; 2000 Nov; 1(5):361. PubMed ID: 11062488
[No Abstract] [Full Text] [Related]
26. A horseshoe crab receptor structurally related to Drosophila Toll.
Inamori K; Koori K; Mishima C; Muta T; Kawabata S
J Endotoxin Res; 2000; 6(5):397-9. PubMed ID: 11521062
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus.
Han SB; Yoon YD; Ahn HJ; Lee HS; Lee CW; Yoon WK; Park SK; Kim HM
Int Immunopharmacol; 2003 Sep; 3(9):1301-12. PubMed ID: 12890428
[TBL] [Abstract][Full Text] [Related]
28. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.
Ahmad-Nejad P; Häcker H; Rutz M; Bauer S; Vabulas RM; Wagner H
Eur J Immunol; 2002 Jul; 32(7):1958-68. PubMed ID: 12115616
[TBL] [Abstract][Full Text] [Related]
29. Immunology: a block at the toll gate.
Mak TW; Yeh WC
Nature; 2002 Aug; 418(6900):835-6. PubMed ID: 12192398
[No Abstract] [Full Text] [Related]
30. Toll-like receptor signaling in anti-cancer immunity.
Okamoto M; Sato M
J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
[TBL] [Abstract][Full Text] [Related]
31. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways.
Haeberle HA; Takizawa R; Casola A; Brasier AR; Dieterich HJ; Van Rooijen N; Gatalica Z; Garofalo RP
J Infect Dis; 2002 Nov; 186(9):1199-206. PubMed ID: 12402188
[TBL] [Abstract][Full Text] [Related]
32. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
Netea MG; Van Der Graaf CA; Vonk AG; Verschueren I; Van Der Meer JW; Kullberg BJ
J Infect Dis; 2002 May; 185(10):1483-9. PubMed ID: 11992285
[TBL] [Abstract][Full Text] [Related]
33. The role of Toll-like receptors and MyD88 in innate immune responses.
Akira S; Hoshino K; Kaisho T
J Endotoxin Res; 2000; 6(5):383-7. PubMed ID: 11521059
[TBL] [Abstract][Full Text] [Related]
34. Extolling the diversity of bacterial endotoxins.
Golenbock DT; Fenton MJ
Nat Immunol; 2001 Apr; 2(4):286-8. PubMed ID: 11276196
[No Abstract] [Full Text] [Related]
35. The Lps locus: genetic regulation of host responses to bacterial lipopolysaccharide.
Qureshi ST; Gros P; Malo D
Inflamm Res; 1999 Dec; 48(12):613-20. PubMed ID: 10669111
[TBL] [Abstract][Full Text] [Related]
36. The potential of Lps(d)/Ran cDNA in gene therapy for septic shock.
Wong PM; Sultzer BM; Chung SW
J Hematother Stem Cell Res; 2000 Oct; 9(5):629-34. PubMed ID: 11091486
[No Abstract] [Full Text] [Related]
37. Hedgehogs like it sweet, too.
Beenken A; Mohammadi M
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17069-70. PubMed ID: 17088529
[No Abstract] [Full Text] [Related]
38. The integrin family of cell surface receptors.
DeSimone DW; Stepp MA; Patel RS; Hynes RO
Biochem Soc Trans; 1987 Oct; 15(5):789-91. PubMed ID: 2826269
[No Abstract] [Full Text] [Related]
39. Immunotoxicity Considerations for Next Generation Cancer Nanomedicines.
Hannon G; Lysaght J; Liptrott NJ; Prina-Mello A
Adv Sci (Weinh); 2019 Oct; 6(19):1900133. PubMed ID: 31592123
[TBL] [Abstract][Full Text] [Related]
40. Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.
Dobrovolskaia MA
J Control Release; 2015 Dec; 220(Pt B):571-83. PubMed ID: 26348388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
